Jasper Therapeutics, Inc. (JSPR) KPIs and segments

JSPRNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 5/30

$13.37−1.39 (-9.42%)

Close on Nov 12, 2026Market cap $444.88MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Jasper Therapeutics's business

Coming soon

This tab will track the numbers specific to Jasper Therapeutics's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?